{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:55:10Z","timestamp":1790780110780,"version":"4.1.0"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,30]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>West Nile virus (WNV) can cause anterior\/intermediate uveitis with characteristic multifocal chorioretinal lesions. Literature on acute manifestations is robust; however there is limited data describing the full spectrum of uveitic manifestations of WNV, treatments in the acute and chronic phase, as well as long-term sequelae.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective observational study from three academic uveitis practices. Patients diagnosed with WNV based on serologic and imaging findings were selected; data collected included demographics, ocular and systemic co-morbidities, ophthalmic examination findings, and treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Eleven patients were included between 2015 to 2023, with a mean follow-up of 128 weeks (\u223c 2.5 years). The average patient was a 60-year-old Caucasian (64%) woman (55%); 27% of patients had diabetes. Fifty-five percent presented with 20\/20-20\/40 Snellen visual acuity. Importantly, 73% of patients in this cohort were hospitalized due to encephalitis or meningitis. Acute findings included anterior inflammation (8 [36.4%] eyes), vitreous inflammation (9 [40.9%] eyes), cystoid macular edema (CME) (6 [27.3%] eyes), non-occlusive retinal vasculitis (5 [22.7%]), and 1 (4.5%) eye with occlusive retinal vasculitis. Two (9.1%) eyes developed secondary peripheral retinal neovascularization requiring anti-vascular endothelial growth factor treatment or laser panretinal photocoagulation. Eight (36.4%) eyes were initially treated with systemic steroids, and 4 (18.2%) eyes required immunomodulatory therapy (IMT) for recurrent CME and retinal vasculitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>WNV uveitis often has a self-limited course but can be intractable in some patients, with long-term control needed for CME and retinal vasculitis with systemic IMT. Ophthalmologists must be aware of the rarer complications that may require intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000005025","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:00:35Z","timestamp":1790776835000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A Multi-Institutional Study on West Nile Virus Uveitis: Treatment, Complications, and Long-Term Outcomes"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1880-3982","authenticated-orcid":false,"given":"Tedi","family":"Begaj","sequence":"first","affiliation":[{"name":"Associated Retinal Consultants\/Beaumont Health, Royal Oak, Michigan, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zujaja","family":"Tauqeer","sequence":"additional","affiliation":[{"name":"Associated Retinal Consultants\/Beaumont Health, Royal Oak, Michigan, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Illinois Eye and Ear, University of Illinois, Chicago, Illinois USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Marie","family":"Lobo-Chan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Illinois Eye and Ear, University of Illinois, Chicago, Illinois USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Williams","sequence":"additional","affiliation":[{"name":"Associated Retinal Consultants\/Beaumont Health, Royal Oak, Michigan, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy D.","family":"Wolfe","sequence":"additional","affiliation":[{"name":"Associated Retinal Consultants\/Beaumont Health, Royal Oak, Michigan, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Eliott","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Sobrin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"Faia","sequence":"additional","affiliation":[{"name":"Associated Retinal Consultants\/Beaumont Health, Royal Oak, Michigan, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000005025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:00:36Z","timestamp":1790776836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000005025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000005025","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]}}}